SSRI induced hypnic jerks: A case series.
Level 4 - case-series / case-control
Case series of four patients without controls
PubMed 37645359 · doi:10.4103/indianjpsychiatry.indianjpsychiatry_207_23
What was done
Clinical presentation and management were described for four patients who developed hypnic jerks associated with selective serotonin reuptake inhibitor (SSRI) therapy (escitalopram, sertraline, or fluoxetine). Patients underwent sleep-induced electroencephalogram (EEG) evaluations and were treated with clonazepam.
What was found
Four cases of hypnic jerks were linked to three different SSRIs (escitalopram, sertraline, fluoxetine). Sleep-induced EEG was normal in all four cases (4/4). Clonazepam was reported to be effective in reducing symptoms. Exact numerical metrics, drug dosages, and timelines were not reported in the abstract.
Why it matters
This report suggests that SSRI-associated hypnic jerks may represent a broader antidepressant class effect rather than being restricted solely to escitalopram, and highlights clonazepam as a potential management option.
Limits
The study is limited to a very small sample size (n = 4) with an uncontrolled, retrospective design that cannot prove causality. The abstract provides no quantitative outcome measures, drug dosing schedules, or long-term follow-up details, and confounding by underlying psychiatric distress or sleep disturbances cannot be excluded.
Cited by
- supports Hypnic jerks occur specifically during Stage 1 sleep.